Invanz Sandbox: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
Invanz (Ertapenem) is a 1-beta-methyl carbapenem | Invanz (Ertapenem) is a 1-beta-methyl carbapenem antibiotic that is designed to treat multi drug resistant bacterial infections such as intra-abdominal infections, skin and skin suture infections, community-acquired pneumonia, complicated urinary tract infections including pyelonephritis, acute pelvic infections, and can be used as a prophylactic measure prior to colorectal surgery. Invanz is an injectable antibiotic that can be administered intramuscularly <ref>Merck, Sharp, and Dohme Corporation. Highlight of Prescribing Information: Invanz. http://www.merck.com/product/usa/pi_circulars/i/invanz/invanz_pi.pdf (accessed November, 12 2016)</ref><ref name="merck">...</ref>. | ||
<Structure load='Pbp2.pdb' size='300' frame='X' align='right' caption='Penicillin Binding Protein Structure that is attacked by the beta-lactam ring of Invanz to inhibit cell wall synthesis of a variety of bacteria' scene='Insert optional scene name here' /> | <Structure load='Pbp2.pdb' size='300' frame='X' align='right' caption='Penicillin Binding Protein Structure that is attacked by the beta-lactam ring of Invanz to inhibit cell wall synthesis of a variety of bacteria' scene='Insert optional scene name here' /> | ||
